These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20919693)

  • 1. Toward drug delivery into the brain: synthesis, characterization, and preliminary in vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles.
    Molnár E; Barbu E; Lien CF; Górecki DC; Tsibouklis J
    Biomacromolecules; 2010 Nov; 11(11):2880-9. PubMed ID: 20919693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of alkylglyceryl-functionalized chitosan nanoparticles as permeating vectors for the blood-brain barrier.
    Lien CF; Molnár E; Toman P; Tsibouklis J; Pilkington GJ; Górecki DC; Barbu E
    Biomacromolecules; 2012 Apr; 13(4):1067-73. PubMed ID: 22409486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain.
    Wang ZH; Wang ZY; Sun CS; Wang CY; Jiang TY; Wang SL
    Biomaterials; 2010 Feb; 31(5):908-15. PubMed ID: 19853292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering butylglyceryl-modified polysaccharides towards nanomedicines for brain drug delivery.
    Bostanudin MF; Lalatsa A; Górecki DC; Barbu E
    Carbohydr Polym; 2020 May; 236():116060. PubMed ID: 32172875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S; Sahoo SK
    Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions.
    Martins GO; Segalla Petrônio M; Furuyama Lima AM; Martinez Junior AM; de Oliveira Tiera VA; de Freitas Calmon M; Leite Vilamaior PS; Han SW; Tiera MJ
    Carbohydr Polym; 2019 Jul; 216():332-342. PubMed ID: 31047074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of chitosan and chitosan derivative nanoparticles containing insulin for oral administration.
    Hecq J; Siepmann F; Siepmann J; Amighi K; Goole J
    Drug Dev Ind Pharm; 2015; 41(12):2037-44. PubMed ID: 26006329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and evaluation of anti-neuroexcitation peptide (ANEP) loaded N-trimethyl chitosan chloride nanoparticles for brain-targeting.
    Wang S; Jiang T; Ma M; Hu Y; Zhang J
    Int J Pharm; 2010 Feb; 386(1-2):249-55. PubMed ID: 19900520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
    Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
    J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation.
    Toman P; Lien CF; Ahmad Z; Dietrich S; Smith JR; An Q; Molnár É; Pilkington GJ; Górecki DC; Tsibouklis J; Barbu E
    Acta Biomater; 2015 Sep; 23():250-262. PubMed ID: 25983313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
    Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
    Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
    Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
    Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vivo tumor targeting of pluronic-based nano-carriers.
    Kim JY; Choi WI; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 Oct; 147(1):109-17. PubMed ID: 20600404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and characterization of intranasal mucoadhesive nanoparticulates and thermo-reversible gel of levodopa for brain delivery.
    Sharma S; Lohan S; Murthy RS
    Drug Dev Ind Pharm; 2014 Jul; 40(7):869-78. PubMed ID: 23600649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
    Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
    Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
    Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.